Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
to determine the efficacy of telaprevir administered as 750 mg every 8 hours (q8h) in combination with pegylated interferon (Peg-IFN)-alfa-2a and ribavirin (RBV) in genotype 1 chronic HCV infected liver transplant patients as measured by sustained virologic response (SVR12planned). SVR12planned is defined as having HCV ribonucleic <25 IU/mL acid (RNA) level 12 weeks after the last planned dose of study medication.
Inclusion criteria
- Chronic Hepatitis C Infection